Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

South Asia has a pattern of learning its hardest lessons too late. Political breakdowns are routinely dismissed as unique – ...

BOSTON, December 16, 2025--(BUSINESS WIRE)--Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs that provide employers with ...

GLP-1 Weight-Loss Drug in Pill Form Shows Promise in Trial By Ernie Mundell HealthDay ReporterTUESDAY, Nov. 25, 2025 (HealthDay News) — New clinical trial results bode well for what could be the first ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Voyager 1 is one of humanity’s most poignant and remarkable ...

THE Primary and Secondary Education ministry has announced the commencement of the Form 1 online application system. The platform opens when Grade 7 pupils across the country are awaiting results to ...

The Zim government has opened its online platform for Form 1 Boarding places application. The Ministry of Primary and Secondary Education made the announcement ...

Tesla shareholders approved a plan to grant Elon Musk shares worth nearly $1 trillion if he meets ambitious goals, including vastly expanding the company’s stock market valuation. By Rebecca F.

In this lesson students are introduced to Frederick Jackson Turner and how early Census data, when combined visually with maps, effectively demonstrated the end of the frontier. By reading Turner’s ...

The military's reserve components now issue departing reservists a new standard service record that summarizes their periods of active and inactive service as well as their "points" earned toward ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...